Irina Haivas is a Partner on the investment team based in London. She leads on investments in frontier technologies, with an interest in the intersection of biology and engineering, and in enterprise businesses, with an interest in AI/ML applications and tools, data across the stack (from infrastructure to intelligence to automation), and productivity/collaboration. She also leads on opportunities in the bio/healthcare space.
Irina looks for bold mission-driven founders that use first principles to architect a version of the future that changes status quo and tackles hard, high-stakes problems – whether it’s the next wave of enterprise transformation, the digitisation of traditional industries, or the way we work, build and drive human potential itself.
Previously, Irina was a late stage investor at GHO Capital Partners, where she invested in enterprise software, tech-enabled services, and applied AI/ML at the intersection of technology and life sciences. Before that, Irina was part of the leadership team of Bain & Co. in Europe and U.S., where she worked directly with over 30 companies on innovation and product strategy, go to market, and M&A. She also spent time building a regional sales strategy at Medtronic, one of the world’s largest medical engineering companies.
While her first love was mathematics, Irina trained in medicine and was a surgical fellow at Harvard Medical School before completing an MSc (Dist) in International Health Policy at London School of Economics. Irina speaks Romanian, English, German, conversational French and enough Italian to get around.
Irina is into all things health and wellness; she is an all round fitness lover whether it’s HIIT or yoga, and likes to try out new (science backed) biohacks. A self-declared ‘global citizen’ from an early age, she worked in 10 countries and travelled to over 50; she loves to dive into new places and cultures, and is always planning the next adventure to a far away destination with patchy network but great photography captions.